Liability reform

American Medical Association President Donald J. Palmisano, M.D., J.D., issued the following statement supporting S. 2061.

Related Videos
Related Content

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Sofwave Precise SUPERB Applicator FDA Cleared for Improving Facial Lines, Wrinkles

March 16th 2023

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Sofwave Precise SUPERB Applicator FDA Cleared for Improving Facial Lines, Wrinkles

March 16th 2023

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Sofwave Precise SUPERB Applicator FDA Cleared for Improving Facial Lines, Wrinkles

March 16th 2023

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023
© 2023 MJH Life Sciences

All rights reserved.